(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Quarter results tomorrow
(tns 2024-05-06)
Expected move: +/- 0.00%
-0.16% $ 0.191
Live Chart Being Loaded With Signals
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada...
Stats | |
---|---|
Dzisiejszy wolumen | 11 680.00 |
Średni wolumen | 3 003.00 |
Kapitalizacja rynkowa | 5.74M |
EPS | $0 ( 2024-02-12 ) |
Następna data zysków | ( $0 ) 2024-05-06 |
Last Dividend | $0.500 ( 2008-08-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.53 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-28 | Riva Sheppard | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Kay Christina | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Masi Dina | Buy | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
84.20 |
Last 98 transactions |
Buy: 38 374 999 | Sell: 953 334 |
Integrated BioPharma, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Integrated BioPharma, Finanse
Annual | 2023 |
Przychody: | $50.67M |
Zysk brutto: | $4.06M (8.01 %) |
EPS: | $-0.00110 |
FY | 2023 |
Przychody: | $50.67M |
Zysk brutto: | $4.06M (8.01 %) |
EPS: | $-0.00110 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Przychody: | $56.25M |
Zysk brutto: | $6.55M (11.65 %) |
EPS: | $0.130 |
Financial Reports:
No articles found.
Integrated BioPharma, Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 2008-08-19 |
Last Dividend | $0.500 | 2008-08-19 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.500 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.59 | -- |
Div. Sustainability Score | 2.86 | |
Div.Growth Potential Score | 0.996 | |
Div. Directional Score | 1.930 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
CSBB | Ex Dividend Knight | 2023-09-01 | Quarterly | 0 | 0.00% | |
WCRS | Ex Dividend Junior | 2023-08-21 | Quarterly | 0 | 0.00% | |
BABB | Ex Dividend King | 2023-09-27 | Quarterly | 0 | 0.00% | |
SFDL | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
PPBN | Ex Dividend Knight | 2023-08-17 | Quarterly | 0 | 0.00% | |
HRNNF | Ex Dividend Knight | 2023-09-12 | Quarterly | 0 | 0.00% | |
ENBP | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
CMTV | Ex Dividend Knight | 2023-10-12 | Quarterly | 0 | 0.00% | |
UEPEP | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
RSRV | Ex Dividend Junior | 2023-06-06 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00615 | 1.500 | -0.123 | -0.185 | [0 - 0.5] |
returnOnAssetsTTM | -0.0150 | 1.200 | -0.499 | -0.599 | [0 - 0.3] |
returnOnEquityTTM | -0.0205 | 1.500 | -1.339 | -2.01 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.93 | 0.800 | 0.372 | 0.298 | [1 - 3] |
quickRatioTTM | 0.765 | 0.800 | -0.203 | -0.162 | [0.8 - 2.5] |
cashRatioTTM | 0.125 | 1.500 | -0.414 | -0.621 | [0.2 - 2] |
debtRatioTTM | 0.0884 | -1.500 | 8.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -27.32 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.122 | -1.500 | 9.51 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0535 | 1.000 | -2.44 | -2.44 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0109 | 1.000 | -2.22 | -2.22 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.125 | 1.000 | -0.419 | -0.419 | [0.2 - 2] |
assetTurnoverTTM | 2.43 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 2.86 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -14.90 | 1.000 | -1.606 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0205 | 2.50 | -0.861 | -2.01 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.110 | 1.500 | -2.60 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00453 | 1.000 | -2.39 | 0 | [0.1 - 0.5] |
Total Score | 0.996 |
Integrated BioPharma,
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej